Resveratrol potentially increased the tumoricidal effect of doxorubicin on SKOV3 cancer stem cells in vitro.
cancer stem cells
doxorubicin
drug resistance
resveratrol
Journal
Journal of cellular biochemistry
ISSN: 1097-4644
Titre abrégé: J Cell Biochem
Pays: United States
ID NLM: 8205768
Informations de publication
Date de publication:
May 2019
May 2019
Historique:
received:
24
08
2018
accepted:
31
10
2018
pubmed:
5
1
2019
medline:
5
1
2019
entrez:
5
1
2019
Statut:
ppublish
Résumé
Ovarian cancer is associated with a high percentage of recurrence of tumor and resistance to chemotherapy. Cancer stem cells (CSCs) form a rare population with a significant capacity to begin and expand malignant diseases. Eliminating the drug resistance of CSCs by factors that have fewer side effects to the patient is vital. To investigate the effect of resveratrol (RES) and doxorubicin (DOX) on drug resistance and apoptosis of CSCs; at the first, isolation of CSCs from SKOV3 ovarian carcinoma cells and their dosage adjustment (IC
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
8430-8437Subventions
Organisme : Tabriz University of Medical Sciences
ID : 95/86
Informations de copyright
© 2019 Wiley Periodicals, Inc.